--- title: "在美國以美國存託憑證形式交易的亞洲股票在週一交易中大幅上漲" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/280185890.md" description: "在美國交易的亞洲股票的美國存託憑證顯著上漲，標普亞洲 50 ADR 指數上漲了 2.43%，達到 2,622.72。顯著上漲的股票包括蔚來 (+6.6%)、野村控股 (+4.8%) 和 J and Friends (+4.4%)。來自北亞的下跌股票包括 51Talk (-6.6%) 和蘑菇街 (-5.7%)。在南亞，Sify Technologies (+4%) 和 PLDT (+2.9%) 領漲，而 HDFC 銀行和如瑞迪博士均下跌了 0.5%" datetime: "2026-03-23T14:48:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280185890.md) - [en](https://longbridge.com/en/news/280185890.md) - [zh-HK](https://longbridge.com/zh-HK/news/280185890.md) --- # 在美國以美國存託憑證形式交易的亞洲股票在週一交易中大幅上漲 10:48 AM EDT, 03/23/2026 (MT Newswires) -- Asian equities traded in the US as American depositary receipts opened sharply higher Monday morning, rising 2.43% to 2,622.72 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by electric vehicle maker NIO (NIO), which advanced 6.6%. It was followed by lender Nomura (NMR) and fintech firm J and Friends ( JF ) , which climbed 4.8% and 4.4%, respectively. The decliners from North Asia were led by education company 51Talk Online Education Group ( COE ) and fashion platform MOGU ( MOGU ) , which fell 6.6% and 5.7%, respectively. They were followed by fintech company Jiayin Group ( JFIN ) and game live-streaming service DouYu International ( DOYU ) , which dropped 3.7% and 2.9%, respectively. From South Asia, the gainers were led by IT firm Sify Technologies ( SIFY ) and telecommunications operator PLDT ( PHI ) , which rose 4% and 2.9%, respectively. They were followed by telecommunications operator Telekomunikasi Indonesia (TLK) and IT company Infosys (INFY), which were up 2.7% and 2.2%, respectively. The only decliners from South Asia were lender HDFC Bank ( HDB ) and pharmaceutical company Dr. Reddy's Laboratories (RDY), which were off 0.5% each. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相關股票 - [AIA.US](https://longbridge.com/zh-HK/quote/AIA.US.md) - [HDB.US](https://longbridge.com/zh-HK/quote/HDB.US.md) - [COE.US](https://longbridge.com/zh-HK/quote/COE.US.md) - [NMR.US](https://longbridge.com/zh-HK/quote/NMR.US.md) - [SIFY.US](https://longbridge.com/zh-HK/quote/SIFY.US.md) - [MOGU.US](https://longbridge.com/zh-HK/quote/MOGU.US.md) - [NIO.SG](https://longbridge.com/zh-HK/quote/NIO.SG.md) - [RDY.US](https://longbridge.com/zh-HK/quote/RDY.US.md) - [PHI.US](https://longbridge.com/zh-HK/quote/PHI.US.md) - [NIO.US](https://longbridge.com/zh-HK/quote/NIO.US.md) - [JF.US](https://longbridge.com/zh-HK/quote/JF.US.md) ## 相關資訊與研究 - [鉅亨速報 - Factset 最新調查：如瑞迪博士 ADR(RDY-US) EPS 預估下修至 0.55 元，預估目標價為 13.27 元](https://longbridge.com/zh-HK/news/286277853.md) - [鉅亨速報 - Factset 最新調查：如瑞迪博士 ADR(RDY-US) EPS 預估下修至 0.64 元，預估目標價為 13.44 元](https://longbridge.com/zh-HK/news/286098145.md) - [大行報告丨花旗：小鵬 GX 定價有正面驚喜](https://longbridge.com/zh-HK/news/287145735.md) - [蔚來披露首個碳減排目標並將高管薪酬與ESG目標掛鈎](https://longbridge.com/zh-HK/news/287041843.md) - [共信-KY 衝刺全球取證 預計 Q3 提交肺癌新藥馬、菲上市許可申請](https://longbridge.com/zh-HK/news/282019888.md)